• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-30
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Edema (1820); Hemorrhage/Bleeding (1888); Neurological Deficit/Dysfunction (1982); Seizures (2063); Shaking/Tremors (2515); Confusion/ Disorientation (2553); No Code Available (3191)
Event Date 01/09/2019
Event Type  Injury  
Manufacturer Narrative
Date of birth: (b)(6): exact date is unknown.Additional suspect medical device components involved in the event: product family: dbs-ipg-r-mri, upn: (b)(4), model: db-1200, serial: (b)(4), batch: 736752.Product family: dbs-linear leads: upn: (b)(4), model: db-2202-30, serial: (b)(4), batch: 5079520.A review of the manufacturing documentation for the two leads and the ipg revealed that no anomalies or deviations potentially related to the event occurred during manufacturing.A review of the sterilization documentation for the devices was found to be satisfactory.
 
Event Description
A report was received that the patient, that is enrolled in the (b)(6) clinical study, developed post-operative bleeding around the left electrode which was moderate in severity.A computed tomography scan confirmed bleeding from the puncture passage left frontal and suspected bleeding from the puncture passage right frontal.It was then observed that the patient developed postoperative bleeding subcortically around the right electrode which was moderate in severity.A second computed tomography scan taken several days later showed increasing edema with constant bleeding on the left electrode and no bleeding of the puncture passage on the right with perifocal edema.The patient then experienced a focal epileptic seizure which was moderate in severity.The patient underwent rehabilitation treatment to address the bleeding, was treated with medication to address the epileptic seizure, and his admission was prolonged, and was subsequently discharged.The bleeding was assessed as having a causal relationship to the procedure and possible relationship to the device.The seizure was assess as having a probable relationship to the procedure and possible relationship to the hardware.The event has resolved, and the patient recovered.
 
Manufacturer Narrative
Additional information was received that the patient developed a tremor in the right leg, aphasia, episodes of mental confusion, noticeable slowdown, fluctuating orientation with delirium and apathy.
 
Event Description
A report was received that the patient, that is enrolled in the vercise dbs registry clinical study, developed post-operative bleeding around the left electrode which was moderate in severity.A computed tomography scan confirmed bleeding from the puncture passage left frontal and suspected bleeding from the puncture passage right frontal.It was then observed that the patient developed postoperative bleeding subcortically around the right electrode which was moderate in severity.A second computed tomography scan taken several days later showed increasing edema with constant bleeding on the left electrode and no bleeding of the puncture passage on the right with perifocal edema.The patient then experienced a focal epilectic seizure which was moderate in severity.The patient underwent rehabilitation treatment to address the bleeding, was treated with medication to address the epilectic seizure, and his admission was prolonged, and was subsequently discharged.The bleeding was assessed as having a causal relationship to the procedure and possible relationship to the device.The seizure was assess as having a probable relationship to the procedure and possible relationship to the hardware.The event has resolved, and the patient recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key8506366
MDR Text Key141725376
Report Number3006630150-2019-01638
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905271
UDI-Public08714729905271
Combination Product (y/n)N
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date05/25/2020
Device Model NumberDB-2202-30
Device Catalogue NumberDB-2202-30
Device Lot Number5055338
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/19/2019
Initial Date FDA Received04/11/2019
Supplement Dates Manufacturer Received08/19/2019
Supplement Dates FDA Received09/05/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-